BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17577357)

  • 1. Tixocortol pivalate: what is the right concentration?
    Kalavala M; Statham BN; Green CM; King C; Ormerod AD; Sansom J; English JS; Wilkinson MS; Horne H; Gawkrodger D
    Contact Dermatitis; 2007 Jul; 57(1):44-6. PubMed ID: 17577357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid contact hypersensitivity screening in Singapore.
    Khoo BP; Leow YH; Ng SK; Goh CL
    Am J Contact Dermat; 1998 Jun; 9(2):87-91. PubMed ID: 9601908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone.
    Isaksson M; Persson LM
    Am J Contact Dermat; 1998 Jun; 9(2):136-8. PubMed ID: 9601904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact hypersensitivity to epoxy resin, methyldibromoglutaronitrile, tixocortol pivalate and budesonide in Hungary: a study in 1448 patients.
    Pónyai G; Németh I; Husz S; Jurcsik A; Nebenführer L; Dinnyés M; Némethy P; Kohánka V; Temesvári E
    G Ital Dermatol Venereol; 2011 Feb; 146(1):53-6. PubMed ID: 21317857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contact allergy to local steroids. Contact allergy to corticosteroids among consecutively tested patients with eczema].
    Vestergaard L; Andersen KE
    Ugeskr Laeger; 1997 Sep; 159(38):5662-6. PubMed ID: 9340873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patch testing with methyldibromo glutaronitrile, a multicentre study within the EECDRG.
    Gruvberger B; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Frosch PJ; Goossens A; Lahti A; Lindberg M; Menné T; Orton D; Seidenari S
    Contact Dermatitis; 2005 Jan; 52(1):14-8. PubMed ID: 15701124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendation to include methyldibromo glutaronitrile in the European standard patch test series.
    Bruze M; Goossens A; Gruvberger B; ;
    Contact Dermatitis; 2005 Jan; 52(1):24-8. PubMed ID: 15701126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004.
    Zug KA; McGinley-Smith D; Warshaw EM; Taylor JS; Rietschel RL; Maibach HI; Belsito DV; Fowler JF; Storrs FJ; DeLeo VA; Marks JG; Mathias CG; Pratt MD; Sasseville D
    Arch Dermatol; 2008 Oct; 144(10):1329-36. PubMed ID: 18936397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.